VERACYTE, INC. Revenues
VERACYTE, INC. (VCYT) reported Revenues of $23.47 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-10-29
- VERACYTE, INC. revenues for the quarter ending 2018-09-30 was $23.47M, a 33.95% increase year-over-year.
- VERACYTE, INC. revenues for the quarter ending 2017-09-30 was $17.52M.
| Period end | Revenues 3 month | Revenues 9 month |
|---|---|---|
| 2018-09-30 | $23.47M 10-Q · filed 2018-10-29 | $66.26M 10-Q · filed 2018-10-29 |
| 2017-09-30 | $17.52M 10-Q · filed 2018-10-29 | $52.36M 10-Q · filed 2018-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |